Vulnerability · CVE-2025-3760
A stored cross-site scripting (XSS) vulnerability exists with radio button type custom fields in Liferay Portal 7.2.0 through 7.4.3.129, and Liferay DXP 2024.Q4.1 through 2024.Q4.7
Published Apr 17, 2025 · catalog updated Sep 4, 2025 · Liferay DXP
Check if you run it
No confirmed exploitation is on record for CVE-2025-3760. EPSS is 0.27%. Act only if a listed version of Liferay DXP is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium4.8
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.27%
- Remediation
- Advisory link
- Affected products
- vendor Liferay DXP 7.2.10 ≤dxp-20
A stored cross-site scripting (XSS) vulnerability exists with radio button type custom fields in Liferay Portal 7.2.0 through 7.4.3.129, and Liferay DXP 2024.Q4.1 through 2024.Q4.7, 2024.Q3.1 through 2024.Q3.9, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.12, 2023.Q4.0 through 2023.Q4.10, 2023.Q3.1 through 2023.Q3.10, 7.4 GA through update 92, 7.3 GA through update 36, and 7.2 GA through fix pack 20 allows remote authenticated attackers to inject malicious JavaScript into a page.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor Liferay DXP 7.2.10 ≤dxp-207.2.10 ≤dxp-20
How to fix CVE-2025-3760
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2025-3760. EPSS is 0.27%. Act only if a listed version of Liferay DXP is installed.
Which versions are affected?
Compare what you have installed with Liferay DXP 7.2.10 ≤dxp-20 7.2.10 ≤dxp-20. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.27%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Apr 17, 2025 · EUVD
Detected
A stored cross-site scripting (XSS) vulnerability exists with radio button type custom fields in Liferay Portal 7.2.0 through 7.4.3.129, and Liferay DXP 2024.Q4.1 through 2024.Q4.7, 2024.Q3.1 through 2024.Q3.9, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.12, 2023.Q4.0 through 2023.Q4.10, 2023.Q3.1 through 2023.Q3.10, 7.4 GA through update 92, 7.3 GA through update 36, and 7.2 GA throug
Sep 4, 2025 · EUVD
Updated
A stored cross-site scripting (XSS) vulnerability exists with radio button type custom fields in Liferay Portal 7.2.0 through 7.4.3.129, and Liferay DXP 2024.Q4.1 through 2024.Q4.7, 2024.Q3.1 through 2024.Q3.9, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.12, 2023.Q4.0 through 2023.Q4.10, 2023.Q3.1 through 2023.Q3.10, 7.4 GA through update 92, 7.3 GA through update 36, and 7.2 GA throug
Sources
- CVE.orgVulnerability recordCVE-2025-3760
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2025-3760
30-day exploitation probability 0.3%
first.org - EUVDVulnerability recordEUVD-2025-11485
A stored cross-site scripting (XSS) vulnerability exists with radio button type custom fields in Liferay Portal 7.2.0 through 7.4.3.129, and Liferay DXP 2024.Q4.1 through 2024.Q4.7, 2024.Q3.1 through 2024.Q3.9, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.12, 2023.Q4.0
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.